Novartis AG
Tetrahydro-Pyrido-Pyrimidine Derivatives
Last updated:
Abstract:
The invention relates to substituted tetrahydro-pyrido-pyrimidine derivatives of the formula (I), ##STR00001## wherein Y, R.sup.1, R.sup.2 and m are as defined in the description. Such compounds are suitable for the treatment of a disorder or disease which is mediated by the activity of the PI3K enzymes.
Status:
Application
Type:
Utility
Filling date:
30 Jun 2020
Issue date:
17 Dec 2020